Advances in Systemic Lupus Erythematosus (SLE): A case for optimism.
作者信息
Fanouriakis Antonis, Boumpas Dimitrios T
机构信息
Joint Rheumatology Program, Medical School, National and Kapodestrian University of Athens and 4 Department of Medicine, Attikon University Hospital, Athens, Greece.
出版信息
Mediterr J Rheumatol. 2017 Mar 28;28(1):1-3. doi: 10.31138/mjr.28.1.1. eCollection 2017 Mar.
Abstract
摘要
相似文献
1
Advances in Systemic Lupus Erythematosus (SLE): A case for optimism.系统性红斑狼疮（SLE）的进展：乐观的理由。
Mediterr J Rheumatol. 2017 Mar 28;28(1):1-3. doi: 10.31138/mjr.28.1.1. eCollection 2017 Mar.
2
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses' health study cohorts using genetics, family history, and lifestyle and environmental factors.基于遗传学、家族史以及生活方式和环境因素，利用护士健康研究队列预测女性新发系统性红斑狼疮风险的预测模型。
Semin Arthritis Rheum. 2023 Feb;58:152143. doi: 10.1016/j.semarthrit.2022.152143. Epub 2022 Nov 25.
3
The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.不同发病年龄红斑狼疮患者的临床特征差异全景：来自中国的一项横断面多中心研究。
Clin Rheumatol. 2023 Sep;42(9):2353-2367. doi: 10.1007/s10067-023-06661-1. Epub 2023 Jun 13.
4
Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.抗磷脂抗体与系统性红斑狼疮的非血栓形成表现
Lupus. 2018 Apr;27(4):665-669. doi: 10.1177/0961203317734924. Epub 2017 Oct 19.
5
A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.红斑狼疮样中毒性表皮坏死松解症 1 例并文献复习
Lupus. 2013 Jul;22(8):839-46. doi: 10.1177/0961203313492242. Epub 2013 Jun 11.
6
The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.半乳糖凝集素-3在系统性红斑狼疮患者皮肤损伤中的作用。
Lupus. 2018 Apr;27(4):621-627. doi: 10.1177/0961203317736144. Epub 2017 Oct 23.
7
Treatment of systemic lupus erythematosus in 2006.
Joint Bone Spine. 2006 Dec;73(6):591-8. doi: 10.1016/j.jbspin.2006.09.003. Epub 2006 Oct 11.
8
Recent progress in conventional and biologic therapy for systemic lupus erythematosus.系统性红斑狼疮的常规和生物治疗的最新进展。
Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii66-8. doi: 10.1136/annrheumdis-2012-202204. Epub 2012 Dec 19.
9
Recent advances in the treatment of systemic lupus erythematosus with belimumab in children.贝丽珠单抗治疗儿童全身性红斑狼疮的最新进展。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Oct 15;23(10):1069-1074. doi: 10.7499/j.issn.1008-8830.2107153.
10
The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.采用 SLICC 和 ACR 标准正确标记患有皮肤狼疮和系统性红斑狼疮的患者。
Clin Rheumatol. 2018 Mar;37(3):817-818. doi: 10.1007/s10067-018-3999-0. Epub 2018 Feb 1.
引用本文的文献
1
Interferon Inhibition in SLE: From Bench to Bedside.系统性红斑狼疮中的干扰素抑制：从实验室到临床
Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):354-364. doi: 10.31138/mjr.010324.iis. eCollection 2024 Jun.
2
The NYMERIA Study: A Real-World, Multicentre Contemporary Assessment of Disease- and Patient-Related Burden and Treatment Strategies in Patients with Systemic Lupus Erythematosus.NYMERIA研究：对系统性红斑狼疮患者疾病及患者相关负担与治疗策略的真实世界、多中心当代评估
Mediterr J Rheumatol. 2024 Jun 30;35(Suppl 2):392-401. doi: 10.31138/mjr.160524.tns. eCollection 2024 Jun.
本文引用的文献
1
Lupus thrombocytopenia: pathogenesis and therapeutic implications.狼疮性血小板减少症：发病机制及治疗意义
Mediterr J Rheumatol. 2017 Mar 28;28(1):20-26. doi: 10.31138/mjr.28.1.20. eCollection 2017 Mar.
2
Interferon targeted therapies in systemic lupus erythematosus.系统性红斑狼疮的干扰素靶向治疗
Mediterr J Rheumatol. 2017 Mar 28;28(1):13-19. doi: 10.31138/mjr.28.1.13. eCollection 2017 Mar.
3
Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies.系统性红斑狼疮的病情活动：诊断、危险因素及预防策略
Mediterr J Rheumatol. 2017 Mar 28;28(1):4-12. doi: 10.31138/mjr.28.1.4. eCollection 2017 Mar.
4
Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.自身免疫性疾病相关免疫性血小板减少症的临床特征：一项回顾性研究。
Medicine (Baltimore). 2016 Dec;95(50):e5565. doi: 10.1097/MD.0000000000005565.
5
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.个性化免疫监测揭示了对狼疮患者进行分层的分子网络。
Cell. 2016 Jun 2;165(6):1548-1550. doi: 10.1016/j.cell.2016.05.057.
6
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).狼疮低疾病活动状态（LLDAS）的定义和初步验证。
Ann Rheum Dis. 2016 Sep;75(9):1615-21. doi: 10.1136/annrheumdis-2015-207726. Epub 2015 Oct 12.
7
Targeting of type I interferon in systemic autoimmune diseases.系统性自身免疫性疾病中I型干扰素的靶向治疗
Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16.
8
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.狼疮肾炎诱导治疗的多靶点治疗：一项随机试验。
Ann Intern Med. 2015 Jan 6;162(1):18-26. doi: 10.7326/M14-1030.
9
The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.患者 flares 的数量会影响系统性红斑狼疮的累积损伤：来自多民族拉丁美洲队列的数据。
Ann Rheum Dis. 2015 Jun;74(6):1019-23. doi: 10.1136/annrheumdis-2013-204620. Epub 2014 Feb 13.
10
Adherence to treatment in systemic lupus erythematosus patients.系统性红斑狼疮患者的治疗依从性。
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):329-40. doi: 10.1016/j.berh.2013.07.001.
Zotero 插件